Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABVC
TXMD
Add up to 3 more stocks
ABVC
ABVC BioPharma, Inc.
-1.02%
$0.97-0.01Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$25.22M
52W Range
$0.71 - $3.40
TXMD
TherapeuticsMD, Inc.
+0.50%
$2.02+0.01Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$23.38M
52W Range
$1.03 - $2.95
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | 11.88 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.45 | 0.86 |
| P/S Ratio | N/A | 7.15 |
| P/FCF Ratio | N/A | 7.49 |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 100.0% |
| Operating Margin | 0.0% | -139.4% |
| Net Margin | 0.0% | -6.6% |
| ROE | -76.8% | -0.8% |
| ROA | -40.7% | -0.6% |
| ROIC | -53.3% | -11.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.07 | 3.22 |
| Quick Ratio | 0.07 | 3.22 |
| Debt/Equity | 0.17 | 0.20 |
| Interest Coverage | -17.20 | -526.75 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.